CGIM
PFE icon

Capital Group Investment Management’s Pfizer PFE Stock Holding History

Capital Group Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Buy
94,728
+3,068
+3% +$80.3K 0.34% 70
2026
Q1 		$2.57M Hold
91,660
– – 0.44% 57
2025
Q4 		$2.28M Buy
91,660
+34,716
+61% +$875K 0.37% 69
2025
Q3 		$1.45M Buy
56,944
+3,611
+7% +$89.1K 0.24% 96
2025
Q2 		$1.29M Hold
53,333
– – 0.23% 92
2025
Q1 		$1.35M Hold
53,333
– – 0.28% 91
2024
Q4 		$1.41M Hold
53,333
– – 0.27% 88
2024
Q3 		$1.54M Buy
53,333
+3,003
+6% +$87.6K 0.31% 84
2024
Q2 		$1.41M Buy
50,330
+3,929
+8% +$108K 0.3% 82
2024
Q1 		$1.29M Sell
46,401
-29,837
-39% -$828K 0.23% 109
2023
Q4 		$2.19M Sell
76,238
-4,699
-6% -$142K 0.23% 115
2023
Q3 		$2.68M Buy
80,937
+2,811
+4% +$99.4K 0.17% 106
2023
Q2 		$2.87M Sell
78,126
-281,222
-78% -$10.9M 0.14% 104
2023
Q1 		$14.7M Sell
359,348
-168,235
-32% -$7.27M 0.78% 57
2022
Q4 		$27M Buy
+527,583
New +$25.3M 1.04% 34

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Group Investment Management's PFE Position: Q2 2026 in Review

Capital Group Investment Management increased its Pfizer (PFE) stake by 3.3% in Q2 2026, buying an estimated $80.3K and bringing the position to 94,728 shares worth $2.28M. The position accounts for 0.34% of the portfolio, ranked #70.

Capital Group Investment Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $27M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capital Group Investment Management held 94,728 shares of Pfizer worth $2.28M as of Q2 2026.
  • Capital Group Investment Management bought 3,068 Pfizer shares in Q2 2026, an estimated $80.3K.
  • Pfizer made up 0.34% of Capital Group Investment Management's portfolio in Q2 2026, its #70 holding.
  • Capital Group Investment Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Capital Group Investment Management's Pfizer position peaked at $27M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capital Group Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.